Global stroke challenges: From COVID-19 to intracerebral hemorrhage and atrial fibrillation

Abstract

Get full access to this article

View all access options for this article.

References

Markus

Brainin

. COVID-19 and stroke – a global World Stroke Organization perspective. Int J Stroke 2020; 15: 361–364.

Nannoni S, de Groot R, Bell S and Markus HS. Stroke in COVID-19. A systematic review and meta-analysis. Int J Stroke 2021; 16(2): 137–149.

Merkler

Parikh

Mir

, et al. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol 2020; 77: 1–7.

Crilly S, Withers SE, Allan SM, Parry-Jones AR and Kasher PR. Revisiting promising preclinical intracerebral hemorrhage studies to highlight repurposable drugs for translation. Int J Stroke 2021; 16(2): 123–136.

Ouyang M, Billot L, Song L, et al. Prognostic significance of early urinary catheterization after acute stroke: secondary analyses of the International HeadPoST Trial. Int J Stroke 2021; 16(2): 200–206.

Lippi G, Sanchis-Gomar F and Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke 2021; 16(2): 217–221.